FAK is among the intracellular pathways that have shown promise as a target in cancer treatment, in addition to other well-known signaling molecules including RAS-RAF-MEK1/2-ERK1/2, CCR2/CCR5, and CXCR4. Here, CCR2 is linked to cancer.